Skip to main content
Nature Communications logoLink to Nature Communications
. 2018 Mar 13;9:16187. doi: 10.1038/ncomms16187

Author Correction: Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target

Peter J Cook, Rozario Thomas, Ram Kannan, Esther Sanchez de Leon, Alexander Drilon, Marc K Rosenblum, Maurizio Scaltriti, Robert Benezra, Andrea Ventura
PMCID: PMC5857674  PMID: 29532792

Nature Communications 8: Article number: 15987; DOI: 10.1038/ncomms15987 (2017); Published: July 11 2017; Updated: March 13 2018

In the original version of this Article, financial support was not fully acknowledged. The PDF and HTML versions of the Article have now been corrected to include the following:

‘This work was supported by grant I10-0095 from the STARR foundation.’


Articles from Nature Communications are provided here courtesy of Nature Publishing Group

RESOURCES